Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06908629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: May 2025 to May 2027
    • Start date: Jul 1, 2024 to Sep 3, 2024
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are: * Can we have a completion rate of at least 80% of participants filling out the screening tool? * Can we determine procedures for patient referrals based on social needs * Can we implement brief interventions based on food access and digital inclusion (ensuring everyone has access to the digital technologies they need to participate in society)
Trial Details
NCT Number NCT06908629
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Conditions
(from sponsor)		 Cancer, Cancer Survivors, Gastrointestinal Cancers, Neuroendocrine Tumors, Multiple Myeloma, Neoplasms
Related terms Gastrointestinal Neoplasms, Multiple Myeloma, Neoplasms, Neuroendocrine Tumors
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov